Drug Type Biological products |
Synonyms |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Egg Hypersensitivity | Phase 2 | United States | 20 Aug 2019 |
Phase 2 | 15 | (AR201 Powder) | owjmwmitdu(lipubucnnr) = fbzdcvkzpy powxnmqsbj (dxluabhxvt, pfegbzduee - kjkoxtkduo) View more | - | 28 Feb 2022 | ||
Placebo powder (Placebo Powder) | owjmwmitdu(lipubucnnr) = brldlplaih powxnmqsbj (dxluabhxvt, xyrxefhgiu - euqjcawtha) View more |